DexCom
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DexCom and other ETFs, options, and stocks.About DXCM
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.
DXCM Key Statistics
DXCM News
Shares of DexCom, Inc. DXCM scaled a new 52-week high of $142.00 on Mar 26, before closing the session marginally lower at $139.93. Over the past year, this Za...
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter. A...
Sadie Stern, EVP Chief Human Resources Officer of DexCom Inc (NASDAQ:DXCM), has sold 4,137 shares of the company on March 25, 2024, according to a recent SEC fi...
Analyst ratings
88%
of 25 ratingsMore DXCM News
In the latest trading session, DexCom (DXCM) closed at $139.93, marking a -0.12% move from the previous day. This change was narrower than the S&P 500's daily l...
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has DexCom (DXCM) been o...
The U.S. District Court for the District of Delaware has ruled that DexCom’s (DXCM) G6 continuous glucose monitors infringe one of three patents held by an Abbo...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about R...
S&P 500 components Dexcom (DXCM), Blackstone (BX) and Royal Caribbean (RCL) lead a list of stocks that also include CyberArk Software (CYBR) and Neurocrine Bios...
DexCom (DXCM) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the ne...